Form 4: Cytokinetics CEO Robert Blum Reports Stock Transactions
SEC Form 4 Filing
Robert Blum, President & CEO of Cytokinetics, reports exercising stock options and selling shares on September 3, 2024.
Summary
- On September 3, 2024, Robert I Blum, President & CEO and Director of Cytokinetics Inc, executed transactions involving the company's common stock.
- Blum exercised non-qualified stock options to acquire 5,000 shares at a price of $6.67 per share.
- Simultaneously, Blum sold 5,000 shares of common stock at a price of $57.03 per share.
- Following these transactions, Blum directly owns 397,456 shares of Cytokinetics common stock.
- Blum also indirectly owns 2,083 shares through The Bridget Blum 2003 Irrevocable Trust and 2,083 shares through The Brittany Blum 2003 Irrevocable Trust.
- He also holds 84,727 non-qualified stock options.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock transactions by a company executive.
Industry Context
Insider transactions are routinely monitored by investors to gauge executive sentiment and potential future performance of the company. Option exercises followed by sales are a common way for executives to realize the value of their stock-based compensation.
Stakeholder Impact
- Shareholders may interpret the CEO's stock sale as a signal, although option exercises and sales are common for executive compensation.
- The transactions have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/23/2016 | Date exercisable for Non-Qualified Stock Option (Right to Buy) |
| 02/23/2026 | Expiration date for Non-Qualified Stock Option (Right to Buy) |
| 09/03/2024 | Date of transaction: exercising stock options and selling shares |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.